Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

New round of financing at Igeneon to advance lead candidates

March 4, 2004

Advanced Viral Research reports in vitro biologic effects of AVR-118

March 3, 2004

Promising results found for an autologous melanoma cancer vaccine

March 2, 2004

SGN-30 receives orphan drug designation for T-cell lymphomas

March 1, 2004

Micromet and Boehringer Ingelheim collaborate on MT-201 manufacturing

Feb. 27, 2004

Seattle Genetics and Abbott sign manufacturing agreement for SGN-30

Feb. 26, 2004

Enrollment scheduled to conclude in pivotal MyVax trial

Feb. 23, 2004

Harvard Group to acquire assets of NexTherapeutics; IND anticipated for NXT-211

Feb. 20, 2004

New phase II study for MT-201 in prostate cancer

Feb. 16, 2004

Transgene updates status of phase II trials of MVA-Muc1-IL2

Feb. 12, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...